Keyphrases
Israel
100%
Seroprevalence
23%
Seropositivity
18%
Israeli Population
18%
Shigellosis
17%
Confidence Interval
15%
Epidemiology
14%
Risk Factors
14%
Shigella Sonnei
14%
Seroepidemiology
10%
COVID-19
10%
Jews
9%
Campylobacter
9%
Virus
8%
Recent Trends
8%
Salmonella
8%
Cervical Intraepithelial Neoplasia
8%
Cervical Cancer
8%
Wild Poliovirus
8%
Odds Ratio
8%
Laboratory-based Surveillance
8%
Sentinel
8%
Vaccination
7%
Age Groups
7%
Poliovirus Type 1
7%
Campylobacteriosis
7%
Israeli
7%
Environmental Surveillance
7%
Israeli children
7%
Shigella
7%
IgG Antibody
6%
Seropositivity Rate
6%
Bedouin
6%
Serum Bank
6%
Antibody Titer
6%
Surveillance Network
6%
Incidence Rate
5%
Hepatitis E Virus
5%
West Nile Virus
5%
Non-typhoidal Salmonella
5%
Helicobacter Pylori (H. pylori)
5%
Israeli Adolescents
5%
Influenza B
5%
Sporadic Infection
5%
Virus-neutralizing Antibody
5%
Infection Rate
5%
Arab children
5%
Serum Samples
5%
Immunology and Microbiology
Seroprevalence
27%
Seropositivity
22%
Prevalence
20%
Monospecific Antibody
13%
Vaccine Efficacy
12%
Salmonella
11%
Vaccination Policy
9%
Shigella sonnei
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Immunoglobulin G Antibody
8%
ELISA
7%
Influenza
7%
Shigella
7%
Serotype
6%
Serology
6%
Pylorus
5%
Infectious Disease
5%
Influenza A Virus (H1N1)
5%
Helicobacter Pylori
5%
Antibody Titer
5%